Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Enters Into Second Agreement With Korean Drug Screening Company Next&Bio

Dec 19 (Reuters) - Amplia Therapeutics Ltd ATX.AX:

AMPLIA ENTERS INTO SECOND AGREEMENT WITH KOREAN SPECIALIST DRUG SCREENING COMPANY NEXT&BIO TO EXPLORE COMBINATION THERAPY WITH FAK INHIBITOR AND KRAS INHIBITORS

Source text: ID:nGNX7m59dk

Further company coverage: ATX.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news